Pentazocine

Chemical formula: C₁₉H₂₇NO  Molecular mass: 285.431 g/mol  PubChem compound: 441278

Therapeutic indications

Pentazocine is indicated for:

Indication

Population group: only children (1 year - 12 years old)

at least one of
Administration of analgesic
Pain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Administration of analgesic
Pain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pentazocine is contraindicated in the following cases:

Contraindication

at least one of
Respiratory insufficiency
Acute abdomen
Intracranial injury
Crushing injury of skull
Benign intracranial hypertension
Pregnancy
Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: PENTAZOCINE Capsules, hard
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈